Purpose: To study the occurrence and level of diabetic retinopathy (DRP) before and after planned bariatric surgery and to investigate potential risk factors for deterioration of DRP. Methods: The Scandinavian Obesity Surgery Registry (SOReg) was used to identify diabetic patients who underwent gastric bypass (GBP) surgery at three centres in Sweden during [2008][2009][2010]. Information regarding DRP screening was obtained from ophthalmological patient charts. Patients who had DRP screening before and after GBP surgery were included in the study. Results: The survey included 117 patients. Mean age was 50 (SD 10) years, body mass index (BMI) 43 (SD 8) kg/m 2 and HbA1c 64 (SD 18) mmol/mol before surgery. One year post-GBP, BMI was reduced to 31 (SD 6) kg/m 2 . HbA1c was 43 (SD 10) mmol/mol, and in 66% (77/117) treatment for diabetes had been discontinued. Occurrence of DRP before GBP was as follows: no DRP 62%, mild 26%, moderate 10%, severe 0% and proliferative DRP 2%. No significant changes in occurrence of DRP after surgery were observed. Twelve patients (16%) developed mild DRP. In seven patients with pre-existing DRP, deterioration was observed and two of these patients required treatment for sight-threatening DRP. No association between preoperative BMI, HbA1c or reduction in HbA1c and worsening of DRP was found. Conclusion: In a majority of patients, no deterioration of DRP following GBP was observed. Screening for DRP before planned surgery is recommended for all diabetic patients about to undergo bariatric surgery to identify any pre-existing DRP.
Introduction
Obesity is common among persons with diabetes mellitus. In Sweden, more than 28% of patients with type 2 diabetes have a BMI at or above 30 kg/m 2 (National Diabetic Register 2016). Bariatric surgery is an effective means to treat severe obesity. Six thousands bariatric surgical procedures are performed yearly in Sweden, of which 16% are carried out in patients with diabetes (SOReg 2011) . Following bariatric surgery, significant weight loss and improved metabolic control is rapidly achieved. In the prospective Swedish Obese Subject (SOS) study, it was found that at 2 years after bariatric surgery (mainly restrictive procedures), 72% of diabetic patients had discontinued diabetic treatment (Sj€ ostr€ om et al. 2004 ). An identical result has been found after GBP surgery in the SOReg cohort 5 years postoperatively (Sundbom et al. 2017) .
Microvascular changes in the retinal blood vessels, DRP, are a common diabetic complication which may become sight-threatening (UKPDS 1991; Lutty 2013) . It is well established that good metabolic control reduces the risk of DRP (DCCT 1995 (DCCT , 2016 UKPDS 1998) . However, it has been shown that rapid improvement in glycaemic control may paradoxically worsen DRP (Van Ballegooie et al. 1984; Henricsson et al. 2002) .
Case reports of severe worsening of DRP following bariatric surgery have been published (Silva et al. 2013) , suggesting that diabetic patients about to undergo obesity surgery may require intensified screening for DRP. Small pilot studies have reported worsening of pre-existing DRP following surgery (Varadhan et al. 2012; Thomas et al. 2014) . In a meta-analysis including 148 patients from four nonrandomized case series, 7.5% of patients without preoperative DRP developed DRP whereas in patients with pre-existing DRP, 23% progressed and 19% improved (Cheung et al. 2015) . Similar results were observed in a recently published small prospective observational study on 51 Danish GBP patients (Brynskov et al. 2016) . However, other findings indicate reduced rate of progression of DRP following bariatric surgery (Amin et al. 2016; Banks et al. 2015) .
There is very limited information on ophthalmological findings in diabetic patients having bariatric surgery in Sweden, and the question about need for intensified screening in these patients has been brought up. The aim of the present survey was to study the occurrence and level of DRP before and after planned bariatric surgery and to investigate potential risk factors for deterioration of DRP in a Swedish cohort of obese diabetic patients.
Materials and methods
The study was conducted in accordance with the tenets of the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Uppsala, Sweden.
The Scandinavian Obesity Surgery Registry (SOReg) is a national quality register for obesity surgery in Sweden which was launched in 2007. The registry covers approximately 99% of all bariatric surgery in Sweden and when validated has been shown to have a high degree of accuracy and reliability (Hedenbro et al. 2015) . The SOReg was used to identify diabetic patients who underwent GBP surgery at three centres in Sweden (University Hospital Uppsala, € Orebro University Hospital and V€ astmanland County Hospital V€ aster as) during 2008-2010. In all, 182 patients with diabetes were identified. According to national registration, four patients had moved out of the area and thus, follow-up data were unavailable. For the remaining 178 patients, ophthalmological patient charts from 2000 to 2014 were collected. Screening for DRP had been performed in 146 patients. In total 117 patients, in whom data from both preand postoperative diabetic screening was available, were included in the study.
From the SOReg, data on age, BMI, occurrence of obesity-related disease such as diabetes and systemic hypertension as well as HbA1c at the time of surgery and at 12 months following GBP were obtained. From ophthalmological patient charts, information regarding screening for DRP was collected. The time interval between GBP and diabetic screening before and after surgery was calculated (months), and the degree of DRP was noted as none, mild, moderate, severe and proliferative DRP. Presence of diabetic macular oedema and any treatment provided for DRP was recorded. 
Results

Patient population
Overall, screening for DRP had been performed in 82% (146/178) patients. The patient cohort consisted of 117 patients who had undergone screening before and after GBP (Table 1) . Screening for DRP was performed on average 14 (SD 14) months before and 16 (SD 14) months after surgery, respectively.
Results at 12 months
Twelve months after GBP, diabetic treatment had been discontinued in 77 of 117 patients (66%). Changes in BMI and HbA1c at 12 months in the patient cohort are presented in Table 1 .
Diabetic retinopathy
The distribution of DRP in the study cohort before and after GBP is presented in Table 2 . There was no significant change in the occurrence of DRP after GBP compared to before surgery in the cohort.
In the 73 patients without DRP before GBP, 12 (16%) patients developed mild DRP. Of the 44 patients who had some degree of DRP before obesity surgery, worsening of the DRP was observed in seven patients (16%). Two patients with moderate DRP developed severe DRP and one patient with preoperative moderate DRP deteriorated to proliferative DRP after GBP.
In this patient, treatment-requiring proliferative DRP was observed 11 months after GBP first in one eye and shortly thereafter also in the other eye. Additionally, this patient developed sight-threatening clinically significant diabetic macular oedema (CSME) bilaterally. Laser treatment was promptly provided.
Among patients with pre-existing DRP, eight of 44 (18%) improved at least one step on the DRP grading scale.
Logistic regression analysis did not demonstrate any association between preoperative HbA1c, preoperative BMI or reduction in HbA1c and deterioration of DRP postoperatively.
Presence of DRP at the postoperative retinopathy screening visit in relation to presence of diabetes at 12 months after GBP surgery is presented in Table 3 . Diabetic retinopathy (DRP) was found in 30/77 (39%) of the patients in whom treatment for diabetes had been discontinued. In almost half of the patients, DRP was observed irrespective of ongoing diabetic treatment or not 12 months after bariatric surgery.
Discussion
The findings in the present study demonstrate that within 1 year following GBP in severely obese diabetic patients, BMI and HbA1c are reduced. Although surgery induces a rapid improvement in metabolic control, no change in occurrence of DRP in a majority of the present patients was seen. However, clinically significant worsening of the DRP requiring treatment was observed in two individuals with preoperative moderate DRP, suggesting that in susceptible patients, preexisting DRP may deteriorate after bariatric surgery. The present registry data demonstrated that 12 months following GBP, BMI and HbA1c were reduced and diabetic treatment could be discontinued in two out of three patients. The proportion of patients without treatment for diabetes was of a similar magnitude in the SOS study (Sj€ ostr€ om et al. 2004) . Further, remission of diabetes has been demonstrated to reduce the rate of micro-and macrovascular complications compared to nonoperated controls (Sj€ ostr€ om et al. 2014). At 5-year follow-up of more than 9000 GBP patients in the SOReg cohort, three out of four diabetics were off their antidiabetic drugs. However, a small number of patients were seen to have relapsed (Sundbom et al. 2017 ). In the whole cohort, pathological fasting plasma glucose and HbA1c values were seen in 6.3% and 7.6%, respectively, indicating that the glucose homoeostasis is not totally restored after bariatric surgery. Long-term follow-up of former diabetics is therefore of great importance. On the other hand, bariatric surgery, and GBP in particular, has been demonstrated to lower the incidence of diabetes, and subsequent DRP, in obese patients (Carlsson et al. 2012; Sundbom et al. 2017) .
In our study, progression of DRP, either new mild DRP or worsening of pre-existing DRP, was observed in 16% of patients, which is in line with findings in the meta-analysis performed by Cheung et al. 2015 . Lower rates of development of new DRP or worsening of pre-existing DRP have been noted by Brynskov et al. (2016) and Amin et al. (2016) . In these studies, in contrast to the present survey, worsening was defined either as a two-step change in the Wisconsin Epidemiologic Study of Diabetic Retinopathy scale (Brynskov et al. 2016) or deterioration to severe DRP (Amin et al. 2016) , which might explain the difference in results. Improvement in DRP was observed in 18% of patients in the present study which is in line with previous studies (Cheung et al. 2015; Brynskov et al. 2016) .
In our study, there was no association between preoperative HbA1c, preoperative BMI, reduction in BMI or HbA1c and progression of DRP and thus, no specific risk factors for worsening of DRP after GBP were identified. Clinically significant worsening of the DRP was observed in three individuals with preoperative moderate DRP, two of whom required treatment for sight-threatening DRP. In the case reported by Silva et al. (2013) , sightthreatening DRP was observed following bariatric surgery in a patient with preoperative severe DRP. Furthermore, progression of DRP has been described in patients with severe and very severe preoperative DRP (Thomas et al. 2014) . The probability of having a DRP grade of moderate or higher after obesity surgery has been found to be associated with the magnitude of HbA1c reduction after surgery, shorter postoperative DRP screening interval, more severe preoperative DRP and male gender (Murphy et al. 2015) .
Taken together, the findings indicate that in susceptible patients, pre-existing DRP may deteriorate after bariatric surgery.
One strength with the present study was that the patient cohort was identified in the SOReg, a national quality register for all obesity surgery in Sweden, providing real-life data from a comparably large number of patients. Another strength was that a high proportion of identified patients had been included in a local screening programme for DRP. Weaknesses of the present investigation were the retrospective design and the lack of control group. The expected rate of progression of DRP in the population under study is largely unknown. However, indications of reduced rate of progression of DRP have been observed in diabetic patients following bariatric surgery compared to medically treated obese diabetic patients (Amin et al. 2016; Banks et al. 2015) .
In conclusion, in a majority of patients in this real-life study, no deterioration of DRP following GBP was observed. Screening for DRP before planned surgery is recommended for all diabetic patients about to undergo bariatric surgery to identify any pre-existing moderate DRP at risk of worsening following obesity surgery. A larger, prospective and controlled study with longer follow-up is needed. 
